vs
nVent Electric plc（NVT）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
nVent Electric plc的季度营收约是Revvity的1.4倍（$1.1B vs $772.1M），Revvity净利率更高（12.7% vs 11.1%，领先1.6%），nVent Electric plc同比增速更快（127.3% vs 5.9%），nVent Electric plc自由现金流更多（$165.7M vs $161.8M），过去两年nVent Electric plc的营收复合增速更高（10.4% vs 9.0%）
nVent Electric plc是一家源自英美的跨国企业，主营电气连接及外壳类产品。公司集产品设计、生产、销售为一体，同时提供配套运维服务，旗下产品可实现电气系统的连接、防护与管理，覆盖商业、工业、住宅、基建、数据中心等多元应用场景。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
NVT vs RVTY — 直观对比
营收规模更大
NVT
是对方的1.4倍
$772.1M
营收增速更快
NVT
高出121.5%
5.9%
净利率更高
RVTY
高出1.6%
11.1%
自由现金流更多
NVT
多$3.9M
$161.8M
两年增速更快
NVT
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $772.1M |
| 净利润 | $118.8M | $98.4M |
| 毛利率 | 36.5% | — |
| 营业利润率 | 15.4% | 14.5% |
| 净利率 | 11.1% | 12.7% |
| 营收同比 | 127.3% | 5.9% |
| 净利润同比 | 1010.3% | 3.9% |
| 每股收益（稀释后） | $0.74 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVTRVTY
| Q4 25 | $1.1B | $772.1M | ||
| Q3 25 | $1.1B | $698.9M | ||
| Q2 25 | $963.1M | $720.3M | ||
| Q1 25 | $809.3M | $664.8M | ||
| Q4 24 | $469.2M | $729.4M | ||
| Q3 24 | $782.0M | $684.0M | ||
| Q2 24 | $880.3M | $691.7M | ||
| Q1 24 | $874.6M | $649.9M |
净利润NVTRVTY
| Q4 25 | $118.8M | $98.4M | ||
| Q3 25 | $121.2M | $46.7M | ||
| Q2 25 | $109.5M | $53.9M | ||
| Q1 25 | $360.7M | $42.2M | ||
| Q4 24 | $10.7M | $94.6M | ||
| Q3 24 | $105.0M | $94.4M | ||
| Q2 24 | $111.0M | $55.4M | ||
| Q1 24 | $105.1M | $26.0M |
毛利率NVTRVTY
| Q4 25 | 36.5% | — | ||
| Q3 25 | 37.4% | 53.6% | ||
| Q2 25 | 38.6% | 54.5% | ||
| Q1 25 | 38.8% | 56.5% | ||
| Q4 24 | 37.1% | — | ||
| Q3 24 | 39.8% | 56.3% | ||
| Q2 24 | 41.8% | 55.7% | ||
| Q1 24 | 40.6% | 54.6% |
营业利润率NVTRVTY
| Q4 25 | 15.4% | 14.5% | ||
| Q3 25 | 15.8% | 11.7% | ||
| Q2 25 | 16.3% | 12.6% | ||
| Q1 25 | 16.1% | 10.9% | ||
| Q4 24 | 14.3% | 16.3% | ||
| Q3 24 | 17.0% | 14.3% | ||
| Q2 24 | 19.1% | 12.4% | ||
| Q1 24 | 18.2% | 6.8% |
净利率NVTRVTY
| Q4 25 | 11.1% | 12.7% | ||
| Q3 25 | 11.5% | 6.7% | ||
| Q2 25 | 11.4% | 7.5% | ||
| Q1 25 | 44.6% | 6.4% | ||
| Q4 24 | 2.3% | 13.0% | ||
| Q3 24 | 13.4% | 13.8% | ||
| Q2 24 | 12.6% | 8.0% | ||
| Q1 24 | 12.0% | 4.0% |
每股收益（稀释后）NVTRVTY
| Q4 25 | $0.74 | $0.86 | ||
| Q3 25 | $0.74 | $0.40 | ||
| Q2 25 | $0.67 | $0.46 | ||
| Q1 25 | $2.16 | $0.35 | ||
| Q4 24 | $0.07 | $0.77 | ||
| Q3 24 | $0.62 | $0.77 | ||
| Q2 24 | $0.66 | $0.45 | ||
| Q1 24 | $0.62 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $919.9M |
| 总债务越低越好 | $1.6B | — |
| 股东权益账面价值 | $3.7B | $7.3B |
| 总资产 | $6.9B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.42× | — |
8季度趋势，按日历期对齐
现金及短期投资NVTRVTY
| Q4 25 | — | $919.9M | ||
| Q3 25 | — | $931.4M | ||
| Q2 25 | — | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $1.7B |
总债务NVTRVTY
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.8B | — |
股东权益NVTRVTY
| Q4 25 | $3.7B | $7.3B | ||
| Q3 25 | $3.6B | $7.4B | ||
| Q2 25 | $3.5B | $7.6B | ||
| Q1 25 | $3.6B | $7.6B | ||
| Q4 24 | $3.2B | $7.7B | ||
| Q3 24 | $3.3B | $7.9B | ||
| Q2 24 | $3.3B | $7.9B | ||
| Q1 24 | $3.2B | $7.8B |
总资产NVTRVTY
| Q4 25 | $6.9B | $12.2B | ||
| Q3 25 | $6.8B | $12.1B | ||
| Q2 25 | $6.7B | $12.4B | ||
| Q1 25 | $6.7B | $12.4B | ||
| Q4 24 | $6.7B | $12.4B | ||
| Q3 24 | $6.9B | $12.8B | ||
| Q2 24 | $6.2B | $13.4B | ||
| Q1 24 | $6.2B | $13.4B |
负债/权益比NVTRVTY
| Q4 25 | 0.42× | — | ||
| Q3 25 | 0.44× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 0.67× | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | 0.54× | — | ||
| Q1 24 | 0.55× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $202.4M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $165.7M | $161.8M |
| 自由现金流率自由现金流/营收 | 15.5% | 21.0% |
| 资本支出强度资本支出/营收 | 3.4% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.70× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $371.9M | $509.4M |
8季度趋势，按日历期对齐
经营现金流NVTRVTY
| Q4 25 | $202.4M | $182.0M | ||
| Q3 25 | $219.5M | $138.5M | ||
| Q2 25 | $-16.9M | $134.3M | ||
| Q1 25 | $60.2M | $128.2M | ||
| Q4 24 | $224.6M | $174.2M | ||
| Q3 24 | $197.7M | $147.9M | ||
| Q2 24 | $130.8M | $158.6M | ||
| Q1 24 | $90.0M | $147.6M |
自由现金流NVTRVTY
| Q4 25 | $165.7M | $161.8M | ||
| Q3 25 | $200.9M | $120.0M | ||
| Q2 25 | $-33.8M | $115.5M | ||
| Q1 25 | $39.1M | $112.2M | ||
| Q4 24 | $198.1M | $149.8M | ||
| Q3 24 | $184.8M | $125.6M | ||
| Q2 24 | $112.3M | $136.6M | ||
| Q1 24 | $73.9M | $129.7M |
自由现金流率NVTRVTY
| Q4 25 | 15.5% | 21.0% | ||
| Q3 25 | 19.1% | 17.2% | ||
| Q2 25 | -3.5% | 16.0% | ||
| Q1 25 | 4.8% | 16.9% | ||
| Q4 24 | 42.2% | 20.5% | ||
| Q3 24 | 23.6% | 18.4% | ||
| Q2 24 | 12.8% | 19.7% | ||
| Q1 24 | 8.4% | 20.0% |
资本支出强度NVTRVTY
| Q4 25 | 3.4% | 2.6% | ||
| Q3 25 | 1.8% | 2.6% | ||
| Q2 25 | 1.8% | 2.6% | ||
| Q1 25 | 2.6% | 2.4% | ||
| Q4 24 | 5.6% | 3.4% | ||
| Q3 24 | 1.6% | 3.3% | ||
| Q2 24 | 2.1% | 3.2% | ||
| Q1 24 | 1.8% | 2.7% |
现金转化率NVTRVTY
| Q4 25 | 1.70× | 1.85× | ||
| Q3 25 | 1.81× | 2.97× | ||
| Q2 25 | -0.15× | 2.49× | ||
| Q1 25 | 0.17× | 3.03× | ||
| Q4 24 | 20.99× | 1.84× | ||
| Q3 24 | 1.88× | 1.57× | ||
| Q2 24 | 1.18× | 2.87× | ||
| Q1 24 | 0.86× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVT
| Industrial Sector | $554.0M | 52% |
| Electricaland Fastening Solutions Segment | $278.0M | 26% |
| Energy Sector | $235.0M | 22% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
